© 2020 MJH Life Sciences™ and Neurology Live. All rights reserved.
Movement Disorders
Blarcamesine Safe in Phase 2 Parkinson Disease Dementia Study
October 29, 2020
Article
The company is planning a pivotal trial of blarcamesine in Parkinson disease dementia after submitting results of the phase 2 study to the FDA for regulatory guidance.
Supplementing Clinical Decision-Making in Dystonia With AI
October 27, 2020
Article
Kristina Simonyan, MD, PhD, DrMed, and Davide Valeriani, PhD, discussed the translational potential of DystoniaNet, and its potential to be adjusted for use in additional disease states.
Indu Subramanian, MD: Preventing Social Isolation to Prevent Disease Worsening
October 26, 2020
Video
The director of the VA Southwest Parkinson’s Disease Research, Education and Clinical Centers explained how preventing social isolation—particularly in the time of COVID-19—can help prevent worsened disease states in patients.
NeurologyLive Friday 5 — October 23, 2020
October 23, 2020
Article
Take 5 minutes to catch up on NeurologyLive's highlights from the week ending October 23, 2020.
The Technology Behind Optimizing Parkinson Disease Management
October 23, 2020
Article
Advances in wearables and virtual reality present an opportunity to maximize rehabilitative efforts and improve outcomes.